Stem cells are a special and particularly versatile type of cell found throughout the human body which grow and maintain our many different tissues and organs, and repair them when they're damaged. Since first being isolated in 1982, the standard therapeutic use of stem cells has been to transplant them into a patient’s body to replace damaged tissue, an approach that remains almost universally prevalent.

Numerous studies in the last ten years have shown that stem cells can do far more than simply substitute damaged cells – they also generate secretions, called extracellular vesicles (EVs), which play a critical regenerative role by activating local resident stem cell populations, revitalising blocked or dormant cells, minimizing cell death, and controlling inflammatory and abnormal immune responses.


Wellbeing recommends that EVs are separated from a patient’s own stem cells, harvested from a small sample of fat or blood, and then multiplied in the laboratory. The EVs are then placed in normal saline for infusion back into the patient, delivering a cell-free therapy which is many times more effective than a standard stem cell transplant, and far safer as it avoids the risk of tumour formation or immunological issues.


Wellbeing’s Chief Scientist and his team spent over twenty years researching, developing and performing pre-clinical testing on this approach at UK government-regulated laboratories and now have nearly ten years’ experience of advising and monitoring the successful clinical application of the therapy to patients suffering from a wide array of ailments – from muscular and skeletal injuries to cardiac damage and neurodegenerative diseases.